Method for producing steviol and steviol glycoside by using AOBGL11 homolog

Patent metadata

Field	Value
Publication number	US-10988790-B2
Application number	US-201716303849-A
Country	US
Kind code	B2
Filing date	May 25, 2017
Priority date	May 25, 2016
Publication date	Apr 27, 2021
Grant date	Apr 27, 2021

Abstract

There has been a demand for a new method for producing a steviol glycoside and steviol. The present invention provides a method for producing a steviol glycoside and/or steviol, the method comprising a step of breaking bonds of steviol glycoside: a glucosidic bond at position 13; a glucosyl ester bond at position 19; and/or a glycosidic bond in a side chain (excluding a rhamnoside bond).

First claim

The invention claimed is:

1. A method comprising reacting a protein comprising the amino acid sequence of SEQ ID NO: 2 with a first steviol glycoside.

2. The method according to claim 1 , wherein the first steviol glycoside is selected from the group consisting of steviolmonoside, steviol monoglucosyl ester, rubusoside, steviolbioside, stevioside, rebaudioside B, rebaudioside A, rebaudioside C, rebaudioside D, rebaudioside E, rebaudioside F, rebaudioside M, dulcoside A, steviol glycoside B, steviol glycoside C, and steviol glycoside D.

3. The method according to claim 1 , further comprising obtaining steviol and/or a second steviol glycoside, wherein the second steviol glycoside is different from the first steviol glycoside.

4. The method according to claim 3 , wherein the second steviol glycoside is selected from the group consisting of steviolmonoside, steviolbioside, rebaudioside B, steviol glycoside A, steviol glycoside B, steviol glycoside C, and steviol glycoside D.

5. The method according to claim 1 , wherein the reaction with the first steviol glycoside is performed in the presence of an organic solvent.

6. The method according to claim 5 , wherein the organic solvent is acetonitrile.

7. The method according to claim 1 , wherein a glucosyl ester bond at the 19 position or glycoside bond, except for rhamnoside bond, within a side chain at the 19 position of the first steviol glycoside is preferentially cleaved over glucoside bond at the 13 position or glycoside bond, except for rhamnoside bond, within a side chain at the 13 position thereof.

8. The method according to claim 1 , wherein the first steviol glycoside is a steviol glycoside wherein a branched trisaccharide, disaccharide, or glucose monosaccharide is linked through glucoside bond to the 13 position, and/or a branched trisaccharide, disaccharide, or glucose monosaccharide is linked through a glucosyl ester bond to the 19 position, and wherein:
(1) glycoside bond, except for rhamnoside bond, within the disaccharide or the glucoside bond or glucosyl ester bond of the glucose monosaccharide is preferentially cleaved over the branched trisaccharide;
(2) glucose is preferentially cleaved when xylose and glucose, or rhamnose and glucose are further linked to glucose linked to aglycone;
(3) glycoside bond, except for rhamnoside bond, within the branched trisaccharide at the 19 position is preferentially cleaved over glycoside bond, except for rhamnoside bond, within the branched trisaccharide at the 13 position;
(4) glycoside bond, except for rhamnoside bond, within the branched trisaccharide or disaccharide at the 19 position and the glucosyl ester bond of the glucose monosaccharide at the 19 position is preferentially cleaved over glycoside bond, except for rhamnoside bond, within the disaccharide at the 13 position; and/or
(5) the glucosyl ester bond of the glucose monosaccharide at the 19 position is preferentially cleaved over the glucoside bond of the glucose monosaccharide at the 13 position.

9. A method according to claim 1 wherein the protein is from a non-human transformed cell comprising a polynucleotide selected from the group consisting of polynucleotides (a) and (b) shown below:
(a) a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 1;
(b) a polynucleotide encoding a protein comprising the amino acid sequence of SEQ ID NO: 2.

10. The method according to claim 9 , wherein the polynucleotide is inserted into an expression vector.

11. The method according to claim 9 , wherein the transformed cell is transformed koji mold, transformed yeast, a transformed bacterium, or a transformed plant.

12. A method comprising culturing a non-human transformant capable of producing a first steviol glycoside and comprising a polynucleotide selected from the group consisting of polynucleotides (a) and (b) shown below:
(a) a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 1;
(b) a polynucleotide encoding a protein comprising the amino acid sequence of SEQ ID NO: 2.

13. The method according to claim 12 , wherein the polynucleotide is inserted into an expression vector.

14. The method according to claim 12 , wherein the transformant is transformed koji mold, transformed yeast, a transformed bacterium or a transformed plant.

15. A reaction mixture comprising
(1) a steviol glycoside and
(2)(i) a protein comprising the amino acid sequence of SEQ ID NO: 2 and/or
(ii) an extract or a homogenate of a non-human transformant as defined in claim 12 .

Assignees

• Suntory Holdings Ltd

Inventors

• Ochiai Misa
• Ono Eiichiro

Classifications

• C12N15/52 Primary

  Genes encoding for enzymes or proenzymes · CPC title

• C12N9/24

  acting on glycosyl compounds (3.2) · CPC title

• C12P19/44

  Preparation of O-glycosides, e.g. glucosides {(polysaccharides and not substituted disaccharides C12P19/04, C12P19/12)} · CPC title

• C12N5/10

  Cells modified by introduction of foreign genetic material · CPC title

• C12N15/09

  Recombinant DNA-technology · CPC title